Calquence 100 mg
Calquence 100 mg is a medicine authorised by Swissmedic under authorisation number 68817. The authorisation holder is AstraZeneca AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 04 May 2023 and the authorisation is limited until 03 May 2028. ATC code L01EL02 places the medicine in the group Antineoplastic agents.
| Authorisation number | 68817 |
|---|---|
| Name | Calquence 100 mg |
| Full name | Calquence 100 mg, Filmtabletten |
| Authorisation holder | AstraZeneca AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EL02 |
| First authorisation | 04 May 2023 |
| Authorisation validity | 03 May 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Calquence 100 mg, Filmtabletten | A | 04 May 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | Tablette(n) | L01EL02 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Calquence 100 mg authorised in Switzerland?
Yes. Calquence 100 mg is authorised by Swissmedic under authorisation number 68817, data as of 01 September 2026. The authorisation is limited until 03 May 2028.
Which dispensing category does Calquence 100 mg have?
Calquence 100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Calquence 100 mg?
The authorisation holder is AstraZeneca AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.